News & Views We take a look at some of the exciting diabetes research developments announced in May, including how the long-term benefits of weight loss and metformin could slow type 2 diabetes ...

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

Making strides with stem cells The stem cell therapy research is being led by a biotech company called Vertex. They’re running an early-stage clinical trial in the US testing a new approach to ...

With the right treatment and support, it is possible to live well with diabetes. But without it, devastating diabetes complications can develop, and every week diabetes leads to 2,990 cases of heart ...

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...

Dr Elizabeth Robertson is Director of Research at Diabetes UK. She said: “ We are delighted to be partnering with the NIHR to fund the next critical step in our mission to make type 2 diabetes ...

Smart insulin pens are an exciting recent development for people with diabetes. They can show you if you’ve missed an injection as well as how much insulin you’ve taken and the last time you injected.

The findings lay the foundation for new clinical support that could help thousands of women with gestational diabetes avoid the challenges of insulin treatment and improve health for them and their ...

Our prediction is based on analysis of statistics from Public Health England and The Association of Public Health Observatories. It means that as many as 1-in-10 UK adults could be living with ...

In this month's article:In this month's article: A step forward in making insulin 'smarter' World-first stem cell transplant helps person with type 1 diabetes produce insulin Regenerating cells with ...

What is diabetes stigma? Diabetes stigma can take lots of different forms. It may involve being subjected to a throwaway comment, encountering myths and misconceptions about what diabetes is and what ...

In a clinical trial, teplizumab delayed type 1 diabetes by an average of three years in people who were at high risk of developing the condition. It can now be prescribed in the United States outside ...